Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial)
Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial)
Active, not recruiting · NCT03787680 · Registry updated 2026-03-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial) | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Phase 2 | 2026-03-23 | NCT03787680 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Michigan Rogel Cancer Center | 63 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Michigan Hospital | Ann Arbor | United States | 18 |
| University of Virginia Health System | Charlottesville | United States | 57 |
| Wayne State University/Karmanos Cancer Institute | Detroit | United States | 196 |